
Beedan 50mg Tablet
Marketer
Adley Formulations
Salt Composition
Dasatinib (50mg)
Overview Beedan 50mg Tablet
Chronic myeloid leukemia (CML) patients whose condition doesn't respond to, or who can't tolerate, other treatments may benefit from Beedan 50mg Tablets. This medication can be administered with or without food, but consistent daily timing is recommended for optimal effectiveness. Dosage and frequency are determined by your physician, dependent on your specific needs and subject to change. Strict adherence to your doctor's prescribed regimen is crucial; improper use or overdose can lead to severe adverse effects. Therapeutic benefits may not be evident for weeks or months; discontinue use only under your doctor's direction. Common side effects include nausea, vomiting, abdominal pain, and rash. Increased heart rate, and elevated or low blood pressure are possible; seek immediate medical attention if these occur. Regular blood pressure monitoring may be implemented by your physician. Avoid antacids within two hours of ingestion. Beedan 50mg Tablets can lower blood cell counts, increasing infection risk, necessitating regular blood tests. Inform your healthcare provider of all medications you're taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or blurred vision develops.
Uses of Beedan 50mg Tablet
Chronic myelogenous leukemia, a type of blood cancer
Major Benefits of Beedan 50mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Beedan 50mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Beedan 50mg Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Beedan 50mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Beedan 50mg Tablets can be administered with or without food, although consistent timing is recommended.
How Beedan 50mg Tablet works:
Cancer treatment Beedan 50mg tablets inhibit the activity of a rogue protein responsible for cancerous cell proliferation, thus hindering or arresting tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Beedan 50mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Beedan 50mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening cases, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Beedan 50mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Beedan 50mg Tablet side effects. Exercise caution while driving if you experience dizziness or blurred vision after taking Beedan 50mg Tablet.
KidneySAFE IF PRESCRIBED
The use of Beedan 50mg Tablets in individuals with kidney disease is likely safe. Preliminary evidence indicates dose modification may be unnecessary, however, physician consultation is advised.
LiverSAFE IF PRESCRIBED
Liver impairment does not necessitate a dosage change for Beedan 50mg Tablets, which are considered safe for use in such patients.
What if you forget to take Beedan 50mg Tablet :
Omit a missed Beedan 50mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Beedan 50mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Compounds derived from pyrimidine and thiazole. |
| Addictive | None. |
| Medication Category | Cancer therapeutics |
| Mechanism of Action | Kinase inhibitors targeting tyrosine |
